Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease
- PMID: 9930385
- DOI: 10.1080/00365529850172304
Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease
Abstract
Background: Lansoprazole (LAN) and omeprazole (OME) heal esophagitis effectively and to similar extents, but LAN has a faster effect on the relief of symptoms of gastroesophageal reflux. However, no strict comparison of the two proton pump inhibitors' effect on acid reflux and gastric acidity has been published. The aim of this study was to compare the effects of LAN and OME on gastroesophageal reflux with simultaneous measurements of gastric acidity in patients with established gastroesophageal reflux disease (GERD) and esophagitis.
Methods: Fourteen patients with endoscopically verified erosive esophagitis and with a pretreatment esophageal 24-h pH measurement showing acid reflux to the esophagus participated in the study. This was a double-blind, randomized study with crossover design. Before (day 0) and on the last day (day 5) of each treatment period with encapsulated 30 mg LAN or 20 mg OME daily, 24-h intraesophageal and intragastric acidity were measured with antimony electrodes connected to an ambulatory pH recording system.
Results: Ten of 14 patients completed the study. There were no differences in intragastric or intraesophageal acidity or the number of reflux episodes on day 0 between the two treatments. Both LAN and OME treatments increased the median and nocturnal intragastric pH and decreased the 24-h area under the time curve for intragastric acidity significantly and to about the same extent (79% and 69% acid inhibition by LAN and OME, respectively) (NS). However, the percentage of time with pH below 4 in the esophagus was significantly less during LAN treatment (1.92% +/- 2.29; mean +/- standard deviation) than during OME treatment (4.76% +/- 2.88%) on day 5 (P = 0.002). There were also significantly fewer reflux episodes >5 min during treatment with LAN (1.00 +/- 1.33) than with OME (2.90 +/- 2.42) at the end of the treatment period (P = 0.031).
Conclusions: In this study lansoprazole and omeprazole had a comparable effect on gastric acidity in patients with established GERD with esophagitis. However, 30 mg lansoprazole daily reduced the acidity in the oesophagus and the number of refluxes more effectively than 20 mg omeprazole daily. This might indicate that proton pump inhibitors affect the esophageal clearance and/or influence the lower esophageal sphincter differently.
Similar articles
-
Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.Aliment Pharmacol Ther. 2000 Jun;14(6):709-14. doi: 10.1046/j.1365-2036.2000.00775.x. Aliment Pharmacol Ther. 2000. PMID: 10848653 Clinical Trial.
-
Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.Dig Liver Dis. 2000 Nov;32(8):660-6. doi: 10.1016/s1590-8658(00)80326-6. Dig Liver Dis. 2000. PMID: 11142573 Clinical Trial.
-
Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.J Clin Gastroenterol. 2009 Apr;43(4):323-6. doi: 10.1097/MCG.0b013e31818a386e. J Clin Gastroenterol. 2009. PMID: 18758373 Clinical Trial.
-
pH, healing rate, and symptom relief in patients with GERD.Yale J Biol Med. 1999 Mar-Jun;72(2-3):181-94. Yale J Biol Med. 1999. PMID: 10780580 Free PMC article. Review.
-
Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.Clin Ther. 1993;15 Suppl B:2-13. Clin Ther. 1993. PMID: 7911400 Review.
Cited by
-
Lansoprazole: an update of its place in the management of acid-related disorders.Drugs. 2001;61(12):1801-33. doi: 10.2165/00003495-200161120-00011. Drugs. 2001. PMID: 11693467 Review.
-
The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan.J Gastroenterol. 2006 Jun;41(6):554-61. doi: 10.1007/s00535-006-1804-3. J Gastroenterol. 2006. PMID: 16868803 Clinical Trial.
-
Pharmacology of proton pump inhibitors.Curr Gastroenterol Rep. 2008 Dec;10(6):528-34. doi: 10.1007/s11894-008-0098-4. Curr Gastroenterol Rep. 2008. PMID: 19006606 Free PMC article. Review.
-
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.Eur J Clin Pharmacol. 2004 Oct;60(8):531-9. doi: 10.1007/s00228-004-0804-6. Epub 2004 Sep 2. Eur J Clin Pharmacol. 2004. PMID: 15349707 Clinical Trial.
-
What is potent acid inhibition, and how can it be achieved?Drugs. 2005;65 Suppl 1:13-23. doi: 10.2165/00003495-200565001-00004. Drugs. 2005. PMID: 16335854 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous